HEXO — IPO Roadshow (January 2019)
28 slides from HEXO's IPO roadshow presentation, Jan 22, 2019
Slide 1: The Future of Cannabis. Corporate Presentation
The Future of Cannabis. Trusted. Innovative. Visionary. CORPORATE PRESENTATION January 21, 2019 An amended and restated final base shelf prospectus and a preliminary prospectus supplement containing important information relating to the securities described in this document have been filed with the
Slide 2: Notice
Notice You may obtain the amended and restated final base shelf prospectus, any amendment to the shelf prospectus and any applicable shelf prospectus supplement for free by visiting SEDAR at www.sedar.com or EDGAR on the SEC website at www.sec.gov. These documents may also be obtained: (i) in Canada
Slide 3: Forward-looking statements
Forward-looking statements This presentation on HEXO Corp. (“HEXO” or the “Company”) contains certain “forward-looking information” and “forward-looking statements” (collectively “forward-looking statements”). Forward-looking statements are neither historical facts nor assurances of future performan
Slide 4: Today's Presentation Agenda and Speakers
Today’s Presentation Agenda Who We Are Our Industry Our Strengths Offering Summary Sébastien St-Louis Co-Founder & Chief Executive Officer Former CFO of a manufacturing firm MBA (Finance) from Université du Québec à Montréal Closed over $200M commercial banking and trade finance transactions at EDC
Slide 5: HEXO Creates And Distributes Award-Winning, Innovative Products
HEXO Creates And Distributes Award-Winning, Innovative, Easy-To-Use Products To Serve The Cannabis Market. We Seek To Be The Premier Branded Ingredients For Food (IFF) Cannabis Company In The World. Quebec-based and founded in 2013 Currently listed on the TSX and expected to start trading on the NYS
Slide 6: Investment Highlights
Investment Highlights Focus On Strategic Partnerships By Leveraging “Powered By HEXO” 2 Leading Positions In Domestic Markets 3 Strategically Located Large Scale, Low-Cost Production 4 International Growth Strategy Focused On Europe And LatAm With Near-Term Greece Joint Venture To Forge Entryway Int
Slide 7: Who Is HEXO?
Who Is HEXO? 2017 2018 Mar. 2017 Listed on the TSX-V Jul. 2017 Kosher certification obtained – a Canadian LP first • Elixir – Canada’s first and only cannabis oil sublingual spray – launched Apr. 2018 5-year supply deal with Quebec signed Jun. 2018 First plants in new 250,000 sq. ft. greenhouse • Li
Slide 8: Company Vision Powered By HEXO
Company Vision Powered By HEXO VISION HEXO's vision is to create branded, consistent, quick-on and off cannabis experiences for sleep, sport, diet and fun delivered through a full range of “Powered by HEXO” products developed in partnership with potential Fortune 500 partners. FOUR POSSIBLE OUTCOMES
Slide 9: Overall Strategic Priorities
Overall Strategic Priorities OPERATIONAL SCALABILITY Invest in people, processes and systems to deliver on market demands, adapt to new opportunities and provide users with high-quality products at sustainable operating costs. GLOBAL CANNABIS COMPANY Our top priorities are to execute and deliver on
Slide 10: An Emerging And Rapidly Growing Global Market
An Emerging And Rapidly Growing Global Market North America Canada: Legalized medical and adult use markets throughout the country United States: Farm Bill passing will allow CBD extraction from hemp and removes it from the restricted list Mexico: Legalized medical along with pharmaceutical cannabin
Slide 11: Established Retail Distribution in Canada
Established Retail Distribution in Canada Manitoba Nunavut Saskatchewan New Brunswick Nova Scotia Prince Edward Island Quebec Yukon Alberta British Columbia Newfoundland Northwest Territories Ontario Government Private HEXO has secured the single largest forward supply contract among licensed produc
Slide 12: 1) Leader in Product Innovation
1) Leader in Product Innovation A SAMPLE OF OUR CURRENT PRODUCTS AND WHERE WE WILL BE IN THE NEAR FUTURE USING OUR BEST-IN-CLASS IP PROCESSES IN THE MARKET – CANADA WIDE WHAT’S TO COME… Flower Sublingual Sprays Intimate Oil Decarboxylated powders Soft gel capsules Vapes Topicals Edibles Beverages 20
Slide 13: 2) Focus on Strategic Partnerships – Hub & Spoke Model
What HEXO brings to the partnership: 2) Focus on Strategic Partnerships – Hub & Spoke Model P Innovative product development P Low production cost of cannabis ingredients P Licensed infrastructures P Regulatory know-how P IP portfolio (pending patent approvals) Solid distribution infrastructure and
Slide 14: 2) Focus on Strategic Partnerships – Fortune Partnering
2) Focus on Strategic Partnerships – Fortune 500 Partnering TRUSS Beverages Vapes Edibles Confec- tionary Chocolate Dairy Baked Health and Wellness Cosmetics Vapes Edibles Health & Wellness Beverages Cosmetics The Threat Of Potential Substitution Has Driven Cannabis Onto The Radar Of Various Industr
Slide 15: 2) Focus on Strategic Partnerships – Truss JV
2) Focus on Strategic Partnerships – Truss JV Deep Understanding of Consumer Occasions that Relates to Their Vertical P Canadian Distribution P A Powerful Brand Story P Large Capacity to Produce Cannabis Ingredients - CBD, THC, CBG P Broad Range of Base Products P Innovative Technologies in Our Emul
Slide 16: 3) Leading Positions in Domestic Markets
3) Leading Positions in Domestic Markets SQDC supply contract announced April 2018 with the government of Quebec $1 Billion in potential revenue over 5 years, option to renew one year Largest forward supply contract in the history of the cannabis industry in Canada based on year one volume Take or p
Slide 17: 4) Strategically Located Large Scale, Low-cost Production
4) Strategically Located Large Scale, Low-cost Production Competitive electricity rates P State-of-the-art equipment and operations P Attractive crop yields P Maximum use of natural sunlight P Low Cost Drivers Belleville facility Provincial population of 13.4 million, or approximately 38% of the Can
Slide 18: Gatineau Facility
Gatineau Facility Anticipated annual production capacity of 108,000 kg per year at full capacity 10,000 sq. ft. of advanced automated manufacturing facility for dewaxing, distillation, milling and extraction Preparing for upcoming edible and beverage markets Construction and licensing milestones – o
Slide 19: Belleville Facility
Belleville Facility Centre of excellence for joint ventures in a licensed facility under HEXO’s footprint Up to 2,004,000 sq. ft. available for manufacturing, processing and distribution across Canada Main research, development and production facility for ancillary cannabis products Located on Canad
Slide 20: 5) Growing International Presence
5) Growing International Presence United States Farm bill has been adopted and removes hemp from the US government’s list of controlled substances In the process of assessing adequate supplies for hemp-derived cannabinoids Using our existing intellectual property, we can offer a large range of CBD b
Slide 21: 6) Experienced Management Team With Deep Bench Strength
6) Experienced Management Team With Deep Bench Strength Ed Chaplin Chief Financial Officer 20 years of experience with high growth company Chartered Professional Accountant Has held senior financial positions in software and telecommunications industries Involved in acquisitions totaling approximate
Slide 22: 6) Experienced Management Team With Deep Bench Strength
6) Experienced Management Team With Deep Bench Strength Sonia Isabel VP, Sales 20 years of experience managing large sales and marketing teams Experience includes more than a decade in various senior roles with Société des alcools du Québec (SAQ) Graduate of Université du Québec à Montréal and Unive
Slide 23: Repeatedly Executing On Commitments
Repeatedly Executing On Commitments Reached construction and licensing milestones for the 1 million sq. ft. Gatineau facility expansion on time on December 27th, 2018 Project was announced in December 2017, reaching its goal to be completed in less than a year Recently hired executive in charge of p
Slide 24: Solid Financial Position
Solid Financial Position Selected Balance Sheet Information (as at October 31, 2018, before giving effect to the offering) Cash and cash equivalents $23.3M Short-term investments $148.6M Total Assets2 $383.3M Total Liabilities2 $17.4M Total Debt2 - Shareholders' Equity $365.9M Working Capital2,3 $22
Slide 25: Experienced Board of Directors
Experienced Board of Directors Dr. Michael Munzar Director & Chairman of the Board Over 30 years as a licensed physician Published in numerous peer-reviewed journals, managed medical facilities and designed and conducted pre-clinical studies and clinical trials Vincent Chiara Director, Member of the
Slide 26: Offering Summary
Offering Summary Issuer: HEXO Corp. Issue: Common shares of the Company Amount: Approximately C$50 million (without giving effect to the Over-Allotment Option) Issue Price: To be priced in the context of the market Over-Allotment Option: 15% of the Issue, exercisable in whole or in part at any time
Slide 27: Comparable Company Analysis
Comparable Company Analysis In accordance with Section 9A.3(4)(b) of National Instrument 44-102 – Shelf Distributions, the Company’s comparables, and any disclosure relating to the comparables, have been removed from this template version of this presentation.
Slide 28: Investor Relations
INVESTOR RELATIONS HEXO Corp 490 Boulevard St-Joseph, suite 204 Gatineau, Qc J8Y 3Y7 CONTACT 1-866-438-8429 invest@hexo.com